294 related articles for article (PubMed ID: 16615136)
21. In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5-aminolevulinic acid.
van Veen RL; Aalders MC; Pasma KL; Siersema PD; Haringsma J; van de Vrie W; Gabeler EE; Robinson DJ; Sterenborg HJ
Lasers Surg Med; 2002; 31(5):299-304. PubMed ID: 12430146
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats.
Krueger T; Pan Y; Tran N; Altermatt HJ; Opitz I; Ris HB
Lasers Surg Med; 2005 Oct; 37(4):271-7. PubMed ID: 16245295
[TBL] [Abstract][Full Text] [Related]
23. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
Chin W; Lau W; Cheng C; Olivo M
Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
[TBL] [Abstract][Full Text] [Related]
25. Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.
Krueger T; Altermatt HJ; Mettler D; Scholl B; Magnusson L; Ris HB
Lasers Surg Med; 2003; 32(1):61-8. PubMed ID: 12516073
[TBL] [Abstract][Full Text] [Related]
26. Response surface methodology: an extensive potential to optimize in vivo photodynamic therapy conditions.
Tirand L; Bastogne T; Bechet D; Linder M; Thomas N; Frochot C; Guillemin F; Barberi-Heyob M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):244-52. PubMed ID: 19604651
[TBL] [Abstract][Full Text] [Related]
27. Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors.
Henderson BW; Gollnick SO; Snyder JW; Busch TM; Kousis PC; Cheney RT; Morgan J
Cancer Res; 2004 Mar; 64(6):2120-6. PubMed ID: 15026352
[TBL] [Abstract][Full Text] [Related]
28. A comparative analysis of phenothiazinium salts for the photosensitisation of murine fibrosarcoma (RIF-1) cells in vitro.
Walker I; Gorman SA; Cox RD; Vernon DI; Griffiths J; Brown SB
Photochem Photobiol Sci; 2004 Jul; 3(7):653-9. PubMed ID: 15239000
[TBL] [Abstract][Full Text] [Related]
29. Cross-linking of signal transducer and activator of transcription 3--a molecular marker for the photodynamic reaction in cells and tumors.
Henderson BW; Daroqui C; Tracy E; Vaughan LA; Loewen GM; Cooper MT; Baumann H
Clin Cancer Res; 2007 Jun; 13(11):3156-63. PubMed ID: 17545518
[TBL] [Abstract][Full Text] [Related]
30. Fluence rate effects in photodynamic therapy of multicell tumor spheroids.
Foster TH; Hartley DF; Nichols MG; Hilf R
Cancer Res; 1993 Mar; 53(6):1249-54. PubMed ID: 8443805
[TBL] [Abstract][Full Text] [Related]
31. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.
Henderson BW; Busch TM; Vaughan LA; Frawley NP; Babich D; Sosa TA; Zollo JD; Dee AS; Cooper MT; Bellnier DA; Greco WR; Oseroff AR
Cancer Res; 2000 Feb; 60(3):525-9. PubMed ID: 10676629
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy: a means to enhanced drug delivery to tumors.
Snyder JW; Greco WR; Bellnier DA; Vaughan L; Henderson BW
Cancer Res; 2003 Dec; 63(23):8126-31. PubMed ID: 14678965
[TBL] [Abstract][Full Text] [Related]
33. Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells.
Hirschberg H; Sun CH; Krasieva T; Madsen SJ
Lasers Surg Med; 2006 Dec; 38(10):939-45. PubMed ID: 17163479
[TBL] [Abstract][Full Text] [Related]
34. The impact of complement activation on tumor oxygenation during photodynamic therapy.
Cecic I; Minchinton AI; Korbelik M
Photochem Photobiol; 2007; 83(5):1049-55. PubMed ID: 17880499
[TBL] [Abstract][Full Text] [Related]
35. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
Busch TM; Xing X; Yu G; Yodh A; Wileyto EP; Wang HW; Durduran T; Zhu TC; Wang KK
Photochem Photobiol Sci; 2009 Dec; 8(12):1683-93. PubMed ID: 20024165
[TBL] [Abstract][Full Text] [Related]
36. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
Chen B; Roskams T; de Witte PA
Lasers Surg Med; 2002; 31(3):158-63. PubMed ID: 12224088
[TBL] [Abstract][Full Text] [Related]
37. Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: phantom and volunteer experiments.
Nyst HJ; van Veen RL; Tan IB; Peters R; Spaniol S; Robinson DJ; Stewart FA; Levendag PC; Sterenborg HJ
Lasers Surg Med; 2007 Sep; 39(8):647-53. PubMed ID: 17886277
[TBL] [Abstract][Full Text] [Related]
38. [Photosensitizer nanoparticles photodynamic therapy on LOVO human colon cancer xenografts in athymic mice].
Qing SH; Li LY; Sheng XH; Ba MC
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):530-3. PubMed ID: 17143803
[TBL] [Abstract][Full Text] [Related]
39. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
James NS; Cheruku RR; Missert JR; Sunar U; Pandey RK
Molecules; 2018 Jul; 23(8):. PubMed ID: 30042350
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.
Schouwink H; Ruevekamp M; Oppelaar H; van Veen R; Baas P; Stewart FA
Photochem Photobiol; 2001 Apr; 73(4):410-7. PubMed ID: 11332037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]